The neurobiology of opioid dependence: implications for treatment

Cited by (504)

Items 101–200 of 504

1. Endothelin ETA receptor antagonist reverses naloxone-precipitated opioid withdrawal in mice
   Shaifali Bhalla, Gwendolyn M. Pais, Melissa A. Tapia, Anil Gulati · 2015 · Canadian Journal of Physiology and Pharmacology
2. Nalbuphine could decrease the rewarding effect induced by tramadol in mice while enhancing its antinociceptive activity
   Rasha Hassan Abdel-Ghany, Mahmoud Nabil, Mohamed Abdel-Aal, Waleed Barakat · 2015 · European Journal of Pharmacology
3. The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: A novel possible therapeutic approach for opioid use disorders
   Beltrán Álvarez-Pérez, Hervé Poras, Rafael J. Maldonado · 2021 · British Journal of Pharmacology
4. Brain opioid segments and striatal patterns of dopamine release induced by naloxone and morphine
   Ehsan Shokri Kojori, Mika Naganawa, Vijay A. Ramchandani, Dean Foster Wong, Gene‐Jack Wang, Nora D. Volkow · 2021 · Human Brain Mapping
5. Machine-learning analysis of opioid use disorder informed by MOR, DOR, KOR, NOR and ZOR-based interactome networks
   Hongsong Feng, Rana Elladki, Jiang Jian, Guo‐Wei Wei · 2023 · Computers in Biology and Medicine
6. Barriers to progressing through a methadone maintenance treatment programme: perspectives of the clients in the Mid-West of Ireland’s drug and alcohol services
   Lisa Moran, Eamon Keenan, Khalifa Elmusharaf · 2018 · BMC Health Services Research
7. Drug Abuse: Classifications, Effects and Risks
   Richard Alecsander Reichert, Kallinca Merillen Silveira, Fernanda Machado Lopes, Denise de MICHELI · 2021 · Springer eBooks
8. Novel Pharmacological Approaches to Drug Abuse Treatment
   Ellen Lockard Edens, Alfredo A. Massa, Ismene L. Petrakis · 2009 · Current topics in behavioral neurosciences
9. Factors associated with low bone density in opioid substitution therapy patients: a systematic review
   Ramli, Fitri Fareez, Syed Hashim, Syed Alhafiz, Mohd Effendy, Nadia · 2021 · International Journal of Medical Sciences
10. Mini review: Potential therapeutic values of mitragynine as an opioid substitution therapy
    Norsyifa Harun, Nur Azzalia Kamaruzaman, Zarif Mohamed Sofian, Zurina Hassan · 2022 · Neuroscience Letters
11. Modeling the Dynamics of Heroin and Illicit Opioid Use Disorder, Treatment, and Recovery
    Sandra Cole, Stephen A. Wirkus · 2022 · Bulletin of Mathematical Biology
12. A Novel Morphine Drinking Model of Opioid Dependence in Rats
    Pablo Berríos‐Cárcamo, Mauricio Quezada, Daniela Santapau, Paola Morales, Belén Olivares, Carolina A. Ponce, Alba Ávila, Cristian De Gregorio, Marcelo Ezquer, Marı́a Elena Quintanilla et al. · 2022 · International Journal of Molecular Sciences
13. Reward devaluation and heroin escalation is associated with differential expression of CRF signaling genes
    Ashley J. McFalls, Caesar G. Imperio, Georgina V. Bixler, Willard M. Freeman, Patricia S. Grigson, Kent E. Vrana · 2015 · Brain Research Bulletin
14. Depression – A major but neglected consequence contributing to the health toll from prescription opioids?
    Benedikt Fischer, Yoko Murphy, Paul A. Kurdyak, Elliot M. Goldner · 2016 · Psychiatry Research
15. Fatty acid amide hydrolase inhibitor URB597 prevented tolerance and cognitive deficits induced by chronic morphine administration in rats
    Parisa Hasanein, Masumeh Ghafari-Vahed · 2015 · Behavioural Pharmacology
16. Translational value of non-human primates in opioid research
    Huiping Ding, Mei‐Chuan Ko · 2021 · Experimental Neurology
17. Using Named Entity Recognition to Identify Substances Used in the Self-medication of Opioid Withdrawal: Natural Language Processing Study of Reddit Data
    Alexander Preiss, Peter Baumgartner, Mark J. Edlund, Georgiy Bobashev · 2022 · JMIR Formative Research
18. Confounding of the Comparative Safety of Prenatal Opioid Agonist Therapy
    Susan B. Brogly, Kristen A. Hahn · 2015 · Journal of Addiction Research & Therapy
19. Opioid Initiation to Substance Use Treatment
    Marian Wilson, Michele Rose Shaw, Mary Lee A. Roberts · 2018 · Nursing Research
20. Neuropsychological impairment associated with substance use by physicians
    Alexandria Polles, Michelle K. Williams, Benjamin R. Phalin, Scott A. Teitelbaum, Lisa J. Merlo · 2020 · Journal of the Neurological Sciences
21. The Extract of Corydalis yanhusuo Prevents Morphine Tolerance and Dependence
    Lamees Alhassen, Khawla Q. Nuseir, Allyssa Ha, Warren Phan, Ilias Marmouzi, Shalini Shah, Olivier Civelli · 2021 · Pharmaceuticals
22. The pathophysiology of opioid-induced respiratory depression
    Gaspard Montandon · 2022 · Handbook of clinical neurology
23. Proteomic analysis of protein composition of rat hippocampus exposed to morphine for 10 days; comparison with animals after 20 days of morphine withdrawal
    Hana Ujčíková, Kristína Cechová, Michal Jágr, Lenka Roubalová, Miroslava Vošahlíková, Petr Svoboda · 2020 · PLoS ONE
24. Attitudes toward opioid use disorder pharmacotherapy among recovery community center attendees
    Lauren A. Hoffman, Corrie L. Vilsaint, John Francis Kelly · 2021 · Journal of Substance Abuse Treatment
25. A limited access oral oxycodone paradigm produces physical dependence and mesocorticolimbic region-dependent increases in DeltaFosB expression without preference
    Vishakh Iyer, Taylor J. Woodward, Romario Pacheco, Andrea G. Hohmann · 2021 · Neuropharmacology
26. Salvia officinalis L. attenuates morphine analgesic tolerance and dependence in rats: possible analgesic and sedative mechanisms
    Parisa Hasanein, Masoud Teimuri Far, Abbasali Emamjomeh · 2015 · The American Journal of Drug and Alcohol Abuse
27. Time‐dependent regional brain distribution of methadone and naltrexone in the treatment of opioid addiction
    Belin G. Teklezgi, Annapurna Pamreddy, Sooraj Baijnath, Hendrik Gerhardus Kruger, Tricia Naicker, Nirmala Devi Gopal, Thavendran Govender · 2018 · Addiction Biology
28. ERAS Protocol Options for Perioperative Pain Management of Substance Use Disorder in the Ambulatory Surgical Setting
    Nicholas Zwolinski, Kaiwal Patel, Nalini Vadivelu, Gopal Kodumudi, Alan D. Kaye · 2023 · Current Pain and Headache Reports
29. Prescription Opioid Use Among Young Parents in the United States: Results from the National Longitudinal Study of Adolescent to Adult Health
    Anna E. Austin, Meghan E. Shanahan · 2016 · Pain Medicine
30. The Opioid Crisis: The Surgeon's Role.
    Ross F. Goldberg · 2019 · Advances in Surgery
31. Mind-body approaches targeting the psychological aspects of opioid use problems in patients with chronic pain: evidence and opportunities
    Marc Olivier Martel, Alice Bruneau, Robert Randolph Edwards · 2021 · Translational research
32. Evaluation of an activated carbon-based deactivation system for the disposal of highly abused opioid medications
    Xinyi Gao, Pooja Bakshi, Sindhu S. Ganti, Mahima Manian, Andrew Korey, William Fowler, Ajay K. Banga · 2017 · Drug Development and Industrial Pharmacy
33. A comparative study of the effectiveness of group-based cognitive behavioral therapy and dialectical behavioral therapy in reducing depressive symptoms in Iranian women substance abusers
    Sara Sahranavard, Mohammad Reza Miri · 2018 · Psicologia Reflexão e Crítica
34. Spinal Cord Stimulators
    Ajith Malige, Gbolabo O. Sokunbi · 2018 · Spine
35. Clinical and Psychosocial Factors Associated with Quality of Life in Alcohol-Dependent Men with Erectile Dysfunction
    Alexander Michael Ponizovsky · 2008 · The Journal of Sexual Medicine
36. The use of sobriety nutritional therapy in the treatment of opioid addiction
    Cunningham, Patrick M · 2016 · Journal of Addiction Research & Therapy
37. Sublingual dexmedetomidine (BXCL501) reduces opioid withdrawal symptoms: findings from a multi-site, phase 1b/2, randomized, double-blind, placebo-controlled trial
    Jermaine D. Jones, Lavanya Rajachandran, Frank D. Yocca, Robert C. Risinger, Michael De Vivo, Jeff Sabados, FRANCES RUDNICK LEVIN, Sandra D. Comer · 2023 · The American Journal of Drug and Alcohol Abuse
38. Epigenetic regulation in opioid induced hyperalgesia
    Deepa Reddy, Jason R. Wickman, Seena K. Ajit · 2023 · Neurobiology of Pain
39. A review of the kappa opioid receptor system in opioid use
    Salih Çayır, Simon Zhornitsky, Alireza Barzegary, Esteban Sotomayor Carreño, Wonder Sarfo-Ansah, Melissa Christine Funaro, David Matuskey, Gustavo A. Angarita · 2024 · Neuroscience & Biobehavioral Reviews
40. Peripartum buprenorphine and oxycodone exposure impair maternal behavior and increase neuroinflammation in new mother rats
    Courtney N. Dye, Aliyah I. Webb, Madison P. Fankhauser, Jordyn J. Singleton, Aravind Kalathil, Amanda Ringland, Benedetta Leuner, Kathryn M. Lenz · 2024 · Brain Behavior and Immunity
41. Prescribed opioid use is associated with adverse cardiovascular outcomes in community‐dwelling older persons
    S. Liew, Emon Kalyan Chowdhury, M. Ernst, J. Gilmartin-Thomas, C. Reid, A. Tonkin, J. Neumann, J. McNeil, D. Kaye · 2022 · ESC Heart Failure
42. Biological evaluation and molecular docking studies of AA3052, a compound containing a μ-selective opioid peptide agonist DALDA and d-Phe-Phe-d-Phe-Leu-Leu-NH2, a substance P analogue
    Agnieszka Kowalczyk, Patrycja Kleczkowska, Monika Rękawek, Kamila Kulik, Anna Leśniak, Anna Erdei, Attila Borics, Charlotte Martin, Karolina Pawlik, Andrzej Wojciech Lipkowski et al. · 2016 · European Journal of Pharmaceutical Sciences
43. A theoretical framework and nomenclature to characterize the iatrogenic contribution of therapeutic opioid exposure to opioid induced hyperalgesia, physical dependence, and opioid use disorder
    Gillian A. Beauchamp, Lewis S. Nelson, Jeanmarie Perrone, Michael S. Lyons · 2020 · The American Journal of Drug and Alcohol Abuse
44. Clinical and Economic Analysis of Morphine Versus Fentanyl in Managing Ventilated Neonates With Respiratory Distress Syndrome in the Intensive Care Setting
    Dina Abushanab, Omar Alsoukhni, Fouad F. Abounahia, Daoud Al‐Badriyeh · 2019 · Clinical Therapeutics
45. Repetitive hypoglycemia reduces activation of glucose-responsive neurons in C1 and C3 medullary brain regions to subsequent hypoglycemia
    Zohra M. Kakall, Mary Meltem Kavurma, E Myfanwy Cohen, Peter R.C. Howe, Polina E. Nedoboy, Paul M. Pilowsky · 2019 · American Journal of Physiology-Endocrinology and Metabolism
46. “You’re friends until everybody runs out of dope”: A framework for understanding tie meaning, purpose, and value in social networks
    Jerel M. Ezell, Suzan M. Walters, Brooke Olson, Aashna Kaur, Wiley D. Jenkins, John A. Schneider, Mai Tuyet Pho · 2022 · Social Networks
47. Dose-dependent consequences of sub-chronic fentanyl exposure on neuron and glial co-cultures
    Doris Lam, Aimy Sebastian, Chandrakumar Bogguri, Nicholas R. Hum, Alexander Ladd, José Cadena, Carlos A. Valdez, Nicholas O. Fischer, Gabriela G. Loots, Heather A. Enright · 2022 · Frontiers in Toxicology
48. Catechol-O-methyltransferase and dopamine receptor D4 gene variants: Possible association with substance abuse in Bangladeshi male
    Jahanara Akter Sonia, Tohfa Kabir, Md. Monirul Islam, Yearul Kabir · 2021 · PLoS ONE
49. Alterations in neurotransmitter levels and transcription factor expression following intranasal buprenorphine administration
    Sanelisiwe P. Xhakaza, Leon J. Khoza, Advaitaa Meera. Haripershad, Terisha Ghazi, Shanel Dhani, Cosmas Mutsimhu, Molopa J. Molopa, Nithia P. Madurai, Lorna Madurai, Sanil D. Singh et al. · 2021 · Biomedicine & Pharmacotherapy
50. Behavioral and Gene Regulatory Responses to Developmental Drug Exposures in Zebrafish
    Aleksandra M. Mech, Munise Merteroglu, I. Sealy, M. Teh, Richard J. White, W. Havelange, C. Brennan, E. Busch-Nentwich · 2022 · Frontiers in Psychiatry
51. Diels–Alder Adducts of Morphinan-6,8-Dienes and Their Transformations
    János Marton, Anikó Fekete, Paul D. Cumming, Sándor Hosztafi, Pál Mikecz, Gjermund Henriksen · 2022 · Molecules
52. Opioids and Vitamin C: Known Interactions and Potential for Redox-Signaling Crosstalk
    Mackenzie S. Newman, Heather Connery, Jonathan Boyd · 2022 · Antioxidants
53. Cocaine reverses the naltrexone-induced reduction in operant ethanol self-administration: The effects on immediate-early gene expression in the rat prefrontal cortex
    Víctor Echeverry‐Alzate, María Tuda-Arízcun, Kora‐Mareen Bühler, Ángel Santos, Elena Giné, Pedro Olmos, Miguel Ángel Gorriti, Evelio Huertas, Fernando Rodrı́guez de Fonseca, José Antonio López‐Moreno · 2012 · Neuropharmacology
54. Oral and non-oral routes of administration among prescription opioid users: Pathways, decision-making and directionality
    Theodore J. Cicero, Matthew S. Ellis · 2018 · Addictive Behaviors
55. Motivations for Diverted Buprenorphine Use in a Multisite Qualitative Study
    Philip R. Kavanaugh, Katherine J. McLean · 2020 · Journal of Drug Issues
56. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?
    Krishnan V Chakravarthy, Aneesh P. Goel, George M. Jeha, Alan D. Kaye, Paul J. Christo · 2021 · Current Pain and Headache Reports
57. 'Defeating the dragon' - can we afford not to treat patients with heroin dependence?
    Lize Weich · 2010 · South African Journal of Psychiatry
58. Measurement of Drug Liking in Abuse Potential Studies: A Comparison of Unipolar and Bipolar Visual Analog Scales
    Beatrice Setnik, Carl L. Roland, Glenn C. Pixton, Lynn Roy Webster · 2016 · The Journal of Clinical Pharmacology
59. Primary care management of Long-Term opioid therapy
    P. Coffin, Rebecca S. Martinez, B. Wylie, Bunny Ryder · 2022 · Annals medicus
60. Molecular insights into GPCR mechanisms for drugs of abuse
    Omar B. Sánchez-Reyes, Gregory Zilberg, John D. McCorvy, Daniel Wacker · 2023 · Journal of Biological Chemistry
61. Cortisol and β-Endorphin Responses During a Two-Month Exercise Training Program in Patients with an Opioid Use Disorder and on a Substitution Treatment
    Alexandros Psarianos, Αnastassios Philippou, Αrgyro Papadopetraki, Eirini Chatzinikita, Costas Chryssanthopοulos, Apostolos Theos, Athanasios Theocharis, Chara K. Tzavara, Thomas J. Paparrigopoulos · 2025 · International Journal of Molecular Sciences
62. Proteomic analysis reveals brain Rab35 as a potential biomarker of mitragynine withdrawal in rats
    Rahimah Hassan, Nurulhasanah Othman, Sharif Mahsufi Mansor, Christian P. Müller, Zurina Hassan · 2021 · Brain Research Bulletin
63. The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
    Colleen Jordan, Amy L. Kennalley, Tenzing Dolma, Kaitlyn M. Nemes, Alivia Roberts, Brian J. Piper · 2022 · Pharmacy
64. Pain-Related Opioidergic and Dopaminergic Neurotransmission: Dual Meta-Analyses of PET Radioligand Studies
    Sergio Garcia Guerra, Andrea D. Spadoni, Jennifer Mitchell, Irina A. Strigo · 2022 · Brain Research
65. Oxycodone-induced dopaminergic and respiratory effects are modulated by deep brain stimulation
    Jason Yuen, Abhinav Goyal, Aaron E. Rusheen, Abbas Z. Kouzani, Michael Berk, Jee Hyun Kim, Susannah J. Tye, Osama A. Abulseoud, Tyler Oesterle, Charles D. Blaha et al. · 2023 · Frontiers in Pharmacology
66. Transitioning illicit drug preferences and emerging user identities in Ohio: The proliferation of methamphetamine use among African Americans
    Karen Coen Flynn, Lee Hoffer · 2017 · Journal of Ethnicity in Substance Abuse
67. Determination of μ-, δ- and κ-opioid receptors in forebrain cortex of rats exposed to morphine for 10 days: Comparison with animals after 20 days of morphine withdrawal
    Hana Ujčíková, Martina Hlouskova, Kristína Cechová, Katerina Stolarova, Lenka Roubalová, Petr Svoboda · 2017 · PLoS ONE
68. Narcotic Prescriptions following Knee and Shoulder Arthroscopy: A Survey of the Arthroscopy Association of Canada
    Seper Ekhtiari, Nolan S. Horner, Ajaykumar Shanmugaraj, Andrew Duong, Nicole Simunovic, Olufemi Rolland Ayeni · 2020 · Cureus
69. Brain‐derived neurotrophic factor and nerve growth factor concentrations in maternal and umbilical cord blood of opium‐addicted mothers
    Hamed Fanaei, Farideh Riki, Samira Khayat, Morad Bornavard · 2020 · International Journal of Developmental Neuroscience
70. Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal
    Binita Basukala, Sarah L. Rossi, Sally Bendiks, Natalia Gnatienko, Gregory J. Patts, Evgeny M. Krupitsky, Dmitry A. Lioznov, Kaku So‐Armah, Manish Sagar, Christine S. Cheng et al. · 2023 · Viruses
71. Clinical efficacy and patients’ perception of virtual reality during wound care in adults: A systematic review with meta‐analysis of randomised clinical trials
    Masood Mazaheri, Raoul F. Crooijmans, Maya Vereen, Eveline M. L. Corten · 2023 · Wound Repair and Regeneration
72. Evolution and challenges of opioids in pain management: Understanding mechanisms and exploring strategies for safer analgesics
    Toluwalope Temitope Bakare, Henrietta Onyinye Uzoeto, Laywonmen Newon Gonlepa, Samuel Cosmas, Judith Nnedimkpa Ajima, Amarachukwu Vivian Arazu, Somtochukwu Precious Ezechukwu, Chizoba Maryann Didiugwu, Glory Omini Ibiang, Abayomi Gaius Osotuyi et al. · 2024 · Medicinal Chemistry Research
73. Opioid abuse-deterrent strategies: role of clinicians in acute pain management
    Lynn Roy Webster, Michael J. Brennan, Louis Matthew Kwong, Richard Levandowski, Jeffrey A. Gudin · 2015 · Postgraduate Medicine
74. Strategies to build and maintain competence in pain management: Insights from a SIAARTI survey on educational needs among Italian anesthesiologists
    Alessandro Vittori, Marco Cascella, Emiliano Petrucci, Andrea Cortegiani, Elena Giovanna Bignami, Massimo Antonio Innamorato, Arturo Cuomo, Vito Torrano, Flavia Petrini, Antonino Giarratano et al. · 2023 · Pain Practice
75. Modeling Opioid Abuse: A Case Study of the Opioid Crisis in New England
    Cole D. Butler, Peter G. Stechlinski · 2023 · Bulletin of Mathematical Biology
76. A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder
    James C. Miller, Michael A. Brooks, Kelly E. Wurzel, Emily J. Cox, John F. Wurzel · 2023 · Drugs in R&D
77. Methadone directly impairs central nervous system cells in vitro
    Cristian De Gregorio, Javiera Gallardo, Pablo Berríos‐Cárcamo, Álex Handy, Daniela Santapau, Antonia González-Madrid, Marcelo Ezquer, Paola Morales, Alejandro Luarte, Daniela Corvalán et al. · 2024 · Scientific Reports
78. Type of opioid dependence among patients seeking opioid substitution treatment: are there differences in background and severity of problems?
    Bodil Monwell, Per Bülow, Arne Gerdner · 2016 · Substance Abuse Treatment Prevention and Policy
79. Selective Role of RGS9-2 in Regulating Retrograde Synaptic Signaling of Indirect Pathway Medium Spiny Neurons in Dorsal Striatum
    Chenghui Song, Garret R. Anderson, Laurie P. Sutton, Maria T. Dao, Kirill A. Martemyanov · 2018 · Journal of Neuroscience
80. Daily intermittent fasting in mice enhances morphine-induced antinociception while mitigating reward, tolerance, and constipation
    David I. Duron, Filip Hanak, John M. Streicher · 2020 · Pain
81. Transitioning From Intrathecal Hydromorphone to Sublingual Buprenorphine–Naloxone Through Microdosing: A Case Report
    Isaiah T. Crum, VaKara M. Meyer Karre, Alëna A. Balasanova · 2020 · A&A Practice
82. Neural bases for attenuation of morphine withdrawal by Heantos-4: role of l-tetrahydropalmatine
    Soyon Ahn, Maya O. Nesbit, Haiyan Zou, Giada Vacca, Peter Axerio-Cilies, Trần Văn Sung, Anthony G. Phillips · 2020 · Scientific Reports
83. Evaluación de drogadictos con enfermedades asociadas. Aspectos clínicos y terapéuticos de la atención integral
    Roberto Muga, Helena Guardiola, Celestino Rey‐Joly · 2004 · Medicina Clínica
84. Effects of novel beta-lactam, MC-100093, and ceftriaxone on astrocytic glutamate transporters and neuroinflammatory factors in nucleus accumbens of C57BL/6 mice exposed to escalated doses of morphine
    Youssef Sari, Ghadeer M.S. Swiss, Fatin A. Alrashedi, Kholoud A. Baeshen, Sultan A. Alshammari, Shakir D. AlSharari, Nemat Ali, Abdullah F. Alasmari, Ali Alhoshani, Alaa Alnoor Alameen et al. · 2024 · Saudi Pharmaceutical Journal
85. Neurocircuitry underlying the actions of glucagon-like peptide 1 and peptide YY3–36 in the suppression of food, drug-seeking, and anxiogenesis
    Yasmina Dumiaty, Brett M. Underwood, Jenny Phy‐Lim, Melissa J. S. Chee · 2024 · Neuropeptides
86. Weaning From Long-term Opioid Therapy
    Chailee Moss, Carla M. Bossano, Silka Patel, Anna Maya Powell, Rachel Chan Seay, Mostafa A. Borahay · 2019 · Clinical Obstetrics & Gynecology
87. CE: Opioid Use Disorder: Pathophysiology, Assessment, and Effective Interventions
    Kate G. Brown, Bernadette Capili · 2020 · AJN American Journal of Nursing
88. Narcan as biomedical panic: The war on overdose and the harms of harm reduction
    Philip R. Kavanaugh · 2020 · Theoretical Criminology
89. Protocol for a multicenter randomized controlled trial comparing a non-opioid prescription to the standard of care for pain control following arthroscopic knee and shoulder surgery
    The NO PAin Investigators, Aaron Gazendam, Seper Ekhtiari, Nolan S. Horner, Nicole Simunovic, Andrew Duong, Darren L. de SA, Devin C. Peterson, Matthew Denkers, Vickas Khanna et al. · 2021 · BMC Musculoskeletal Disorders
90. Safety Issues of Pharmacological Acute Pain Treatment in Children
    Frédérique Rodieux, Valérie Piguet, Jules Alexandre Desmeules, Caroline Flora Samer · 2019 · Clinical Pharmacology & Therapeutics
91. Substance-Induced Mood Disorders: A Scoping Review
    Ashley E. Kivlichan, Angela Praecht, Cindy Wang, Tony Peter George · 2024 · Current Addiction Reports
92. Attending a Biopsychosocially Focused Buprenorphine Training Improves Clinician Attitudes
    Holly Ann Russell, Brian Smith, Mechelle Sanders, Elizabeth Loomis · 2021 · Frontiers in Psychiatry
93. Alcohol use disorder and associated physical health complications and treatment amongst individuals with and without opioid dependence: A case-control study
    M. Pikovsky, Amy Peacock, Sarah Larney, Briony Larance, Elizabeth Conroy, Elliot C. Nelson, Louisa J Degenhardt · 2018 · Drug and Alcohol Dependence
94. Differences in the Receptor Binding Profile of Lofexidine Compared to Clonidine
    Robert B. Raffa, Joseph V. Pergolizzi, Robert Emory Taylor, Robert P. James, Mark Pirner · 2019 · Pharmacology &amp Pharmacy
95. Adenosine Monophosphate-activated Protein Kinase (AMPK) in serotonin neurons mediates select behaviors during protracted withdrawal from morphine in mice
    Darrell Eacret, Julia Noreck, Julie A. Blendy · 2021 · Behavioural Brain Research
96. Opioid Withdrawal
    Mark S. Wallace, Alexander Papp · 2017 · Springer eBooks
97. Improvement of conditions for the determination of neurotransmitters in rat brain tissue by HPLC with fluorimetric detection
    D Nováková, Karel Kudláček, Jiřı́ Novotný, Karel Nesměrák · 2022 · Monatshefte für Chemie - Chemical Monthly
98. Natural Polyphenols—Resveratrol, Quercetin, Magnolol, and β-Catechin—Block Certain Aspects of Heroin Addiction and Modulate Striatal IL-6 and TNF-α
    Shaimaa Ahmed ElShebiney, Rania Elgohary, Marwa El-Sayed El-Shamarka, Noha A. Mowaad, Osama A. Abulseoud · 2023 · Toxics
99. Computational design and molecular modeling of morphine derivatives for preferential binding in inflamed tissue
    Makena Augenstein, Nayiri Alexander, Matthew Gartner · 2023 · Pharmacology Research & Perspectives
100. The Dopamine Dilemma-Part II: Could Stimulants Cause Tolerance, Dependence, and Paradoxical Decompensation?
     Jason Yanofski · 2011 · PubMed Central